NO20050368L - Minimalt ettergivende volumeffektivt stempel for osmotiske legemiddelleveringssystemer - Google Patents
Minimalt ettergivende volumeffektivt stempel for osmotiske legemiddelleveringssystemerInfo
- Publication number
- NO20050368L NO20050368L NO20050368A NO20050368A NO20050368L NO 20050368 L NO20050368 L NO 20050368L NO 20050368 A NO20050368 A NO 20050368A NO 20050368 A NO20050368 A NO 20050368A NO 20050368 L NO20050368 L NO 20050368L
- Authority
- NO
- Norway
- Prior art keywords
- capsule
- piston
- agent
- osmotic
- drug delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
- A61M2005/14513—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons with secondary fluid driving or regulating the infusion
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39200402P | 2002-06-26 | 2002-06-26 | |
PCT/US2003/020130 WO2004002565A1 (en) | 2002-06-26 | 2003-06-25 | Minimally compliant, volume efficient piston for osmotic drug delivery systems |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20050368L true NO20050368L (no) | 2005-01-24 |
Family
ID=30000792
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20050368A NO20050368L (no) | 2002-06-26 | 2005-01-24 | Minimalt ettergivende volumeffektivt stempel for osmotiske legemiddelleveringssystemer |
Country Status (20)
Country | Link |
---|---|
US (3) | US6939556B2 (es) |
EP (1) | EP1551493B1 (es) |
JP (1) | JP4485945B2 (es) |
KR (1) | KR101046903B1 (es) |
CN (1) | CN100453130C (es) |
AT (1) | ATE376854T1 (es) |
AU (1) | AU2003256308B2 (es) |
BR (1) | BR0312429A (es) |
CA (1) | CA2490544C (es) |
DE (1) | DE60317225T2 (es) |
EC (1) | ECSP055578A (es) |
ES (1) | ES2295642T3 (es) |
HK (1) | HK1080402A1 (es) |
IL (1) | IL165975A (es) |
MX (1) | MXPA05000224A (es) |
NO (1) | NO20050368L (es) |
NZ (1) | NZ537628A (es) |
TW (1) | TW200531709A (es) |
WO (1) | WO2004002565A1 (es) |
ZA (1) | ZA200500744B (es) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY125870A (en) * | 1997-07-25 | 2006-08-30 | Alza Corp | Osmotic delivery system flow modulator apparatus and method |
US7919109B2 (en) | 1999-02-08 | 2011-04-05 | Intarcia Therapeutics, Inc. | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles |
US7258869B1 (en) * | 1999-02-08 | 2007-08-21 | Alza Corporation | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle |
US20040224903A1 (en) * | 2002-12-19 | 2004-11-11 | Stephen Berry | Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device |
US7731947B2 (en) * | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
NZ542779A (en) * | 2003-03-31 | 2009-02-28 | Intarcia Therapeutics Inc | Osmotic pump with means for dissipating internal pressure by allowing osmotic material to be ejected from the container above a set internal pressure |
CA2520766A1 (en) * | 2003-03-31 | 2004-10-21 | Alza Corporation | Osmotic delivery system and method for decreasing start-up times for osmotic delivery systems |
AU2004289218A1 (en) * | 2003-11-06 | 2005-05-26 | Alza Corporation | Modular imbibition rate reducer for use with implantable osmotic pump |
US20050266087A1 (en) * | 2004-05-25 | 2005-12-01 | Gunjan Junnarkar | Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium |
US7619007B2 (en) | 2004-11-23 | 2009-11-17 | Adamas Pharmaceuticals, Inc. | Method and composition for administering an NMDA receptor antagonist to a subject |
DE05852057T1 (de) | 2004-11-23 | 2007-11-29 | Neuromolecular Pharmaceuticals Inc., Emeryville | Zusammensetzung aus einer beschichtung oder matrix mit verzögerter freisetzung und einem nmda-rezeptorantagonisten sowie verfahren zur verabreichung eines solchen nmda-rezeptorantagonisten an ein subjekt |
CA2588296A1 (en) | 2004-11-24 | 2006-06-01 | Neuromolecular Pharmaceuticals, Inc. | Composition comprising an nmda receptor antagonist and levodopa and use thereof for treating neurological disease |
WO2006084139A2 (en) * | 2005-02-03 | 2006-08-10 | Intarcia Therapeutics, Inc. | An implantable interferon-containing device |
WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
US7959938B2 (en) * | 2005-03-15 | 2011-06-14 | Intarcia Therapeutics, Inc. | Polyoxaester suspending vehicles for use with implantable delivery systems |
KR101406456B1 (ko) * | 2005-04-06 | 2014-06-20 | 아다마스 파마슈티칼스, 인코포레이티드 | Cns 장애의 치료를 위한 방법 및 조성물 |
WO2007044910A1 (en) * | 2005-10-13 | 2007-04-19 | Duke University | Compositions for the treatment and prevention of heart disease and methods of using same |
CA2651855C (en) | 2006-05-30 | 2011-08-02 | Intarcia Therapeutics, Inc. | Two-piece, internal-channel osmotic delivery system flow modulator |
EP2359808B1 (en) * | 2006-08-09 | 2013-05-22 | Intarcia Therapeutics, Inc | Osmotic delivery systems and piston assemblies |
ES2402172T3 (es) | 2007-04-23 | 2013-04-29 | Intarcia Therapeutics, Inc | Formulación en suspensión de péptidos insulinotrópicos y usos de los mismos |
US8105261B2 (en) * | 2007-07-02 | 2012-01-31 | Cardiac Pacemakers, Inc. | Osmotic devices and methods for diuretic therapy |
US8394644B2 (en) | 2007-11-08 | 2013-03-12 | Honeywell International Inc. | Microfluidic osmotic pump |
EP2240155B1 (en) | 2008-02-13 | 2012-06-06 | Intarcia Therapeutics, Inc | Devices, formulations, and methods for delivery of multiple beneficial agents |
NZ592113A (en) * | 2008-10-15 | 2012-04-27 | Intarcia Therapeutics Inc | Highly concentrated drug particles, formulations, suspensions and uses thereof |
DK2445571T3 (da) * | 2009-06-26 | 2013-02-25 | Taris Biomedical Inc | Faste lægemiddeltabletter til implanterbare lægemiddelafgivelsesindretninger |
EP3323423B1 (en) | 2009-09-28 | 2020-06-17 | Intarcia Therapeutics, Inc | Rapid establishment and/or termination of substantial steady-state drug delivery |
CN102781259A (zh) | 2009-09-30 | 2012-11-14 | 加利福尼亚大学董事会 | 辅因子及个体使用方法 |
MX2012006320A (es) | 2009-12-02 | 2013-01-18 | Adamas Pharmaceuticals Inc | Composiciones de amantadina y metodos para su uso. |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
AU2012284267B2 (en) | 2011-07-15 | 2017-06-29 | Nusirt Sciences, Inc. | Compositions and methods for modulating metabolic pathways |
US9198454B2 (en) | 2012-03-08 | 2015-12-01 | Nusirt Sciences, Inc. | Compositions, methods, and kits for regulating energy metabolism |
JP6484175B2 (ja) * | 2012-10-12 | 2019-03-13 | イーライ リリー アンド カンパニー | 特に高度に粘性の流体の注射における、化学機関およびそれらの使用の方法 |
CN108452311A (zh) | 2012-11-13 | 2018-08-28 | 纽斯尔特科学公司 | 用于增强能量代谢的组合物和方法 |
WO2014113404A1 (en) | 2013-01-15 | 2014-07-24 | Nusirt Sciences, Inc. | Treating pulmonary conditions |
US10137287B2 (en) * | 2013-03-05 | 2018-11-27 | Taris Biomedical Llc | Drug delivery devices and methods for controlled drug release through device orifice |
SG11201507046UA (en) | 2013-03-15 | 2015-10-29 | Nusirt Sciences Inc | Leucine and nicotinic acid reduces lipid levels |
WO2014204933A1 (en) | 2013-06-17 | 2014-12-24 | Adamas Pharmaceuticals, Inc. | Amantadine compositions and methods of use |
KR20160119863A (ko) | 2014-02-27 | 2016-10-14 | 뉴서트 사이언시스, 인크. | 간 지방증의 감소 또는 예방을 위한 조성물 및 방법 |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
AU2016270984B2 (en) | 2015-06-03 | 2021-02-25 | Intarcia Therapeutics, Inc. | Implant placement and removal systems |
WO2017079467A1 (en) | 2015-11-05 | 2017-05-11 | The General Hospital Corporation | Intrathecal delivery of nucleic acid sequences encoding abcd1 for treatment of adrenomyeloneuropathy |
BR112018012870A2 (pt) | 2015-12-30 | 2018-12-04 | Adamas Pharmaceuticals Inc | métodos e composições para o tratamento de transtornos relacionados à crise |
KR20240037175A (ko) | 2016-05-16 | 2024-03-21 | 인타르시아 세라퓨틱스 인코포레이티드 | 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법 |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
US10406336B2 (en) | 2016-08-03 | 2019-09-10 | Neil S. Davey | Adjustable rate drug delivery implantable device |
EP3528836A1 (en) | 2016-10-20 | 2019-08-28 | Peptron, Inc. | Methods of delivering a neuroprotective polypeptide to the central nervous system |
IL307966A (en) | 2017-01-03 | 2023-12-01 | Intarcia Therapeutics Inc | Methods involving continuous administration of a GLP-1 receptor agonist and co-administration of a drug |
CN110312540B (zh) | 2017-02-17 | 2022-04-05 | 伊莱利利公司 | 通过化学反应输送流体的方法和装置 |
WO2018165462A1 (en) | 2017-03-08 | 2018-09-13 | Intarcia Therapeutics, Inc | Apparatus and methods for administration of a nauseogenic compound from a drug delivery device |
WO2018200885A1 (en) | 2017-04-26 | 2018-11-01 | Neurocentria, Inc. | Magnesium compositions and methods of use |
USD933219S1 (en) | 2018-07-13 | 2021-10-12 | Intarcia Therapeutics, Inc. | Implant removal tool and assembly |
WO2020041774A1 (en) * | 2018-08-23 | 2020-02-27 | Baywind Bioventures | Capsule device for delivery of active agent to gastrointestinal tract |
SG11202103586UA (en) | 2018-10-11 | 2021-05-28 | Intarcia Therapeutics Inc | Human amylin analog polypeptides and methods of use |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4753651A (en) * | 1982-08-30 | 1988-06-28 | Alza Corporation | Self-driven pump |
US4765989A (en) * | 1983-05-11 | 1988-08-23 | Alza Corporation | Osmotic device for administering certain drugs |
US4558888A (en) * | 1983-09-19 | 1985-12-17 | Minnesota Mining And Manufacturing Company | Strip of binding tape |
US4874388A (en) | 1987-06-25 | 1989-10-17 | Alza Corporation | Multi-layer delivery system |
US5728088A (en) * | 1988-12-13 | 1998-03-17 | Alza Corporation | Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals |
US5034229A (en) * | 1988-12-13 | 1991-07-23 | Alza Corporation | Dispenser for increasing feed conversion of hog |
US4969884A (en) | 1988-12-28 | 1990-11-13 | Alza Corporation | Osmotically driven syringe |
US5234424A (en) * | 1988-12-28 | 1993-08-10 | Alza Corporation | Osmotically driven syringe |
US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
US5030216A (en) * | 1989-12-15 | 1991-07-09 | Alza Corporation | Osmotically driven syringe |
US5324280A (en) * | 1990-04-02 | 1994-06-28 | Alza Corporation | Osmotic dosage system for delivering a formulation comprising liquid carrier and drug |
US5180591A (en) | 1990-07-11 | 1993-01-19 | Alza Corporation | Delivery device with a protective sleeve |
US5234692A (en) * | 1990-07-11 | 1993-08-10 | Alza Corporation | Delivery device with a protective sleeve |
US5443459A (en) * | 1991-01-30 | 1995-08-22 | Alza Corporation | Osmotic device for delayed delivery of agent |
US5861166A (en) * | 1991-03-12 | 1999-01-19 | Alza Corporation | Delivery device providing beneficial agent stability |
CN2085662U (zh) * | 1991-03-29 | 1991-10-02 | 毕勇 | 药物″渗透泵″的生产装置 |
US5137727A (en) | 1991-06-12 | 1992-08-11 | Alza Corporation | Delivery device providing beneficial agent stability |
EP0664118B1 (en) | 1991-10-04 | 1999-08-25 | Yoshitomi Pharmaceutical Industries, Ltd. | Sustained-release tablet |
MX9205850A (es) * | 1991-10-10 | 1993-06-01 | Alza Corp | Dispositivos de surtido osmotico de farmaco con materiales de pared hidrofobicos |
US5580578A (en) * | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
US5308348A (en) * | 1992-02-18 | 1994-05-03 | Alza Corporation | Delivery devices with pulsatile effect |
US5209746A (en) | 1992-02-18 | 1993-05-11 | Alza Corporation | Osmotically driven delivery devices with pulsatile effect |
US5456679A (en) * | 1992-02-18 | 1995-10-10 | Alza Corporation | Delivery devices with pulsatile effect |
US5221278A (en) * | 1992-03-12 | 1993-06-22 | Alza Corporation | Osmotically driven delivery device with expandable orifice for pulsatile delivery effect |
US5260069A (en) * | 1992-11-27 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Pulsatile particles drug delivery system |
US5540665A (en) * | 1994-01-31 | 1996-07-30 | Alza Corporation | Gas driven dispensing device and gas generating engine therefor |
US5458888A (en) * | 1994-03-02 | 1995-10-17 | Andrx Pharmaceuticals, Inc. | Controlled release tablet formulation |
US5690952A (en) * | 1995-06-07 | 1997-11-25 | Judy A. Magruder et al. | Implantable system for delivery of fluid-sensitive agents to animals |
US6395292B2 (en) * | 1996-02-02 | 2002-05-28 | Alza Corporation | Sustained delivery of an active agent using an implantable system |
US6132420A (en) * | 1996-02-02 | 2000-10-17 | Alza Corporation | Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems |
EP1238657B1 (en) * | 1996-02-02 | 2004-11-03 | ALZA Corporation | Sustained delivery of an active agent using an implantable system |
US6261584B1 (en) * | 1996-02-02 | 2001-07-17 | Alza Corporation | Sustained delivery of an active agent using an implantable system |
US6156331A (en) * | 1996-02-02 | 2000-12-05 | Alza Corporation | Sustained delivery of an active agent using an implantable system |
ZA981610B (en) * | 1997-03-24 | 1999-08-26 | Alza Corp | Self adjustable exit port. |
MY125870A (en) * | 1997-07-25 | 2006-08-30 | Alza Corp | Osmotic delivery system flow modulator apparatus and method |
MY125849A (en) * | 1997-07-25 | 2006-08-30 | Alza Corp | Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems |
JP4173635B2 (ja) | 1997-12-29 | 2008-10-29 | インターシア セラピューティクス,インコーポレイティド | 膜プラグ保持機構を有する浸透供給装置 |
PT1140012E (pt) * | 1998-12-17 | 2004-05-31 | Alza Corp | Conversao de capsulas de gelatina cheias com liquido em sistemas de libertacao controlada por camadas multiplas |
AU2587002A (en) * | 2000-11-03 | 2002-05-15 | Biomedicines Inc | Method for short-term and long-term drug dosimetry |
-
2003
- 2003-06-25 BR BR0312429-0A patent/BR0312429A/pt not_active IP Right Cessation
- 2003-06-25 DE DE60317225T patent/DE60317225T2/de not_active Expired - Lifetime
- 2003-06-25 WO PCT/US2003/020130 patent/WO2004002565A1/en active IP Right Grant
- 2003-06-25 CN CNB038185156A patent/CN100453130C/zh not_active Expired - Fee Related
- 2003-06-25 JP JP2004517856A patent/JP4485945B2/ja not_active Expired - Lifetime
- 2003-06-25 CA CA2490544A patent/CA2490544C/en not_active Expired - Fee Related
- 2003-06-25 NZ NZ537628A patent/NZ537628A/en not_active IP Right Cessation
- 2003-06-25 AT AT03762060T patent/ATE376854T1/de not_active IP Right Cessation
- 2003-06-25 MX MXPA05000224A patent/MXPA05000224A/es active IP Right Grant
- 2003-06-25 ES ES03762060T patent/ES2295642T3/es not_active Expired - Lifetime
- 2003-06-25 US US10/606,407 patent/US6939556B2/en not_active Expired - Lifetime
- 2003-06-25 KR KR1020047021083A patent/KR101046903B1/ko active IP Right Grant
- 2003-06-25 AU AU2003256308A patent/AU2003256308B2/en not_active Ceased
- 2003-06-25 EP EP03762060A patent/EP1551493B1/en not_active Expired - Lifetime
-
2004
- 2004-03-17 TW TW093107021A patent/TW200531709A/zh unknown
- 2004-12-23 IL IL165975A patent/IL165975A/en unknown
-
2005
- 2005-01-24 NO NO20050368A patent/NO20050368L/no not_active Application Discontinuation
- 2005-01-26 EC EC2005005578A patent/ECSP055578A/es unknown
- 2005-09-06 US US11/219,960 patent/US7112335B2/en not_active Expired - Lifetime
-
2006
- 2006-01-11 HK HK06100435A patent/HK1080402A1/xx not_active IP Right Cessation
- 2006-01-25 ZA ZA200500744A patent/ZA200500744B/xx unknown
- 2006-09-26 US US11/526,983 patent/US20070088337A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1551493B1 (en) | 2007-10-31 |
ECSP055578A (es) | 2005-04-18 |
NZ537628A (en) | 2005-12-23 |
IL165975A (en) | 2009-07-20 |
CN100453130C (zh) | 2009-01-21 |
JP4485945B2 (ja) | 2010-06-23 |
DE60317225D1 (de) | 2007-12-13 |
KR20050026416A (ko) | 2005-03-15 |
ES2295642T3 (es) | 2008-04-16 |
CA2490544A1 (en) | 2004-01-08 |
EP1551493A1 (en) | 2005-07-13 |
CN1671439A (zh) | 2005-09-21 |
HK1080402A1 (en) | 2006-04-28 |
CA2490544C (en) | 2011-04-19 |
AU2003256308A1 (en) | 2004-01-19 |
US6939556B2 (en) | 2005-09-06 |
TW200531709A (en) | 2005-10-01 |
ZA200500744B (en) | 2006-03-29 |
ATE376854T1 (de) | 2007-11-15 |
KR101046903B1 (ko) | 2011-07-06 |
US7112335B2 (en) | 2006-09-26 |
US20040019345A1 (en) | 2004-01-29 |
MXPA05000224A (es) | 2005-06-03 |
US20060111693A1 (en) | 2006-05-25 |
AU2003256308B2 (en) | 2008-07-03 |
US20070088337A1 (en) | 2007-04-19 |
WO2004002565A1 (en) | 2004-01-08 |
JP2005530588A (ja) | 2005-10-13 |
DE60317225T2 (de) | 2008-05-29 |
BR0312429A (pt) | 2005-04-19 |
IL165975A0 (en) | 2006-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20050368L (no) | Minimalt ettergivende volumeffektivt stempel for osmotiske legemiddelleveringssystemer | |
WO2000040218A3 (en) | Osmotic delivery system having space efficient piston | |
BRPI0407366A (pt) | Envoltório com liberação de pressão por ação de came | |
HK1055680A1 (en) | Valve for osmotic devices | |
MX2008001043A (es) | Contenedor. | |
WO2003009884A3 (en) | Elongated syringe | |
DE602004026828D1 (de) | Pharmazeutische abgabesysteme | |
CO4970812A1 (es) | Sistemas de suministro osmotico, ensamble del cuerpo del sistema de suministro osmotico y sistema para controlar la tasa de suministro de agentes beneficos del sistema de suministro osmotico. | |
ES2055649B1 (es) | Bombas osmoticas. | |
WO2008100321A3 (en) | Syringe-in-syringe hollow plunger with integral seal and rupturable membrane and related methods | |
BRPI0515061A (pt) | dispositivo de infusão com reconstituição | |
BRPI0412975A (pt) | espuma penetrante para uso farmacêutico | |
KR910700083A (ko) | 삼투압 구동식 주사기 | |
CO5021220A1 (es) | Dispositivo de suministro de agentes beneficos y metodo para su elaboracion | |
UY27940A1 (es) | Formulacion de anticuerpos humanos para el tratamiento de trastornos asociados con tnf-a | |
UY25055A1 (es) | Formulaciones farmacéuticas que contienen voriconazol | |
AU587877B2 (en) | An artificial gland for implantation in the human body | |
ATE554813T1 (de) | Injektionsvorrichtung mit vereinfachter stopfenrückhaltung | |
ATE529154T1 (de) | Mikrovorrichtung für ein medikamentenabgabesystem mit einer kartusche | |
ES2188249T3 (es) | Contenedor para una administracion intravenosa. | |
EA200700229A1 (ru) | Аппликатор для текучих веществ для медицинского и/или косметического применения | |
CA2492836A1 (en) | Administration device comprising an osmotic drive | |
TW200507838A (en) | Active substance combination comprising a 2,5-dihydroxybenzenesulfonic compound and a potassium ion channel modulator | |
AR038078A1 (es) | Espuma o mousse | |
AR036914A1 (es) | Valvula para fluidos criogenicos, y aplicacion para el empleo de dicha valvula |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |